Figure 2From: In –silico molecular docking analysis of prodigiosin and cycloprodigiosin as COX-2 inhibitors Binding pose of ligand molecules of selected (prodigiosin and cycloprodigiosin) and standard (cellecoxib and rofecoxib) with different COX-2 protein (Docking of ligand into the binding pocket of inflammatory proteins establishing interactions with the active site default colors). Back to article page